Search Results
Results found for "Jana Selent"
- 📰 GPCR Weekly News, January 30 to February 5, 2023
Cannabinoid 1 (CB1 ) receptor arrestin subtype-selectivity and phosphorylation dependence. GPCR Binders, Drugs, and more Ligands selectively tune the local and global motions of neurotensin receptor
- Allosteric Binding Demystified: Smarter GPCR Drug Discovery
Yamina’s Corner reveals how fragmented data, undefined workflows, and ambiguous decision gates silently
- Why “Displacement” Misleads You: Allosteric Binding Demystified
If your project involves GPCRs , functional selectivity , or non-traditional ligands , this session is
- Recurrent high-impact mutations at cognate structural positions in class A G protein-coupled ...
Individual cancer types were enriched for highly impactful, recurrent mutations at selected cognate positions
- 📰 GPCR Weekly News, July 3 to 9, 2023
GPCR Binders, Drugs, and more Rational design of highly stabilized and selective adrenomedullin analogs
- 📰 GPCR Weekly News, October 2 to 8, 2023
determined by NMR via Methyl Relaxation Structural determinants of sphingosine-1-phosphate receptor selectivity
- Phenylalanine 193 in Extracellular Loop 2 of the β 2-Adrenergic Receptor Coordinates β-Arrestin ...
from β-arrestin interaction and demonstrates altered regulatory outcomes downstream of this functional selectivity
- The Impact of CB1 Receptor on Nuclear Receptors in Skeletal Muscle Cells
The impact of ACEA is inhibited by the selective CB1 receptor antagonist, rimonabant.
- 📰 GPCR Weekly News, July 10 to 16, 2023
The potent BECN2-ATG14 coiled-coil interaction is selectively critical for endolysosomal degradation
- Targeted Activation of G-Protein Coupled Receptor-Mediated Ca 2+ Signaling Drives Enhanced Cartilage
Synthetic signaling platforms permitting precise and selective Ca2+ signal transduction can improve dissection
- How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision
From t-test, ANOVA, F-test selection to power analysis that prevents underpowered studies, this module
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
. 📝 Manuscript summary deadline: 23 Sept 2025 📄 Submission deadline: 11 Jan 2026 Submit to Volume II Join the conversation on computational targeting and next-gen selectivity.
- 📰 GPCR Weekly News, May 15 to 21, 2023
GPCRs in Neuroscience Conformationally Selective 2-Aminotetralin Ligands Targeting the alpha2A- and alpha2C-Adrenergic
- 📰 GPCR Weekly News - January 2 to 8, 2023
Industry News Arcoscreen selected by START Lausanne to pitch at the START Global summit on the 23-24th
- 📰 GPCR Weekly News, August 7 to 13, 2023
Submit your abstracts for poster presentation using this form - short talks will be selected from these
- Interacting binding insights and conformational consequences of the differential activity of...
In contrast, when the GPR55 receptor is simulated in complex with the selective agonist ML186, agonist-like
- Assay Volume Control: Your GPCR Drug Discovery Power Lever
, you’ll learn how dialing receptor expression/coupling up or down reveals hidden partial agonism, “silent
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
In July 2025, Superluminal Medicines announced advancing a selective, biased, MC4R agonist small molecule
- Unveiling GPCR Priming: The Hidden Synergy in Cellular Signalling
Traditionally, it was believed that GPCRs selectively activate only their cognate G protein subtypes,
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
dimerization of GLP-1R results in decreased high-affinity binding to its natural ligand, GLP-1, while selectively
- 📰 GPCR Weekly News, January 23 to 29, 2023
Methods & Updates in GPCR Research Development and Characterization of a Highly Selective Turn-On Fluorescent
- 📰 GPCR Weekly News, March 4 to 10, 2024
analysis restricted to variants impacting gene function Interaction modes of human orexin 2 receptor with selective
- Decoding β-Arrestins: from Structure to function
While some receptors selectively activate specific G protein families, others are more versatile, yielding resonance energy transfer (BRET), and multi-color fluorescence microscopy assays employ conformation-selective
- Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal
Screening technologies, structure-informed design, and AI are accelerating target selection.
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
Selection of the libraries typically leads to the isolation of several hundred candidate hits, enriched initial search for potent target receptor modulators is agnostic towards signaling activity because it selects While the native ligand conjugate exhibited poor selectivity for CCR5-expressing cells and was less effective unconjugated MMAE, the Orion CCL5 superagonist analog significantly increased both the potency and selectivity
- 📰 GPCR Weekly Buzz: Exciting Schedule Shifts for Principles of Pharmacology I & II | August 12-18, 2024
conformation with GFP-inspired dyes Structural basis for the ligand recognition and G protein subtype selectivity
- Optimizing HTRF Assays with Fluorescent Ligands: Time-Resolved Fluorescence in GPCR Research
fluorescence chemistry, Celtarys custom-developed ligands offer both high affinity and exceptional selectivity
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
Chem Rev. 2017 Jan 11;117(1):139-155. Greater specificity : allows for selective tracking of receptor subtypes in complex brain tissues. Chem Rev. 2017 Jan 11;117(1):139-155. doi: 10.1021/acs.chemrev.6b00177 Alavi MS, Shamsizadeh A, Azhdari-Zarmehri
- How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)
publications: From on stabilizing RGS2 via modulating its degradation (versus direct inhibition); selectivity
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
Why it matters now: Cleaner signal: Selective excitation + low background reduces false positives in













